Price
Target price
-
-
-
-
-
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Pros and Cons of Cumberland Pharmaceuticals in the next few years
Pros
?
B****
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Cons
?
S********** s********
?
M***** P*******
?
G***** c******* t* c**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Cumberland Pharmaceuticals vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Cumberland Pharmaceuticals | - | - | - | - | - | - | - |
| Pacira Pharmaceuticals | -0.930% | 4.386% | 7.207% | 23.316% | 10.185% | -32.000% | -52.871% |
| Corcept Therapeutics Inc. | 0.060% | 18.155% | 22.758% | 57.410% | 40.099% | 237.324% | 426.374% |
| Supernus Pharmaceuticals | -1.060% | -7.882% | -10.526% | 15.432% | -13.023% | 30.769% | 66.964% |
News
Cumberland Pharmaceuticals Q2 Earnings Call Highlights
Key Points
- Interested in Cumberland Pharmaceuticals Inc.? Here are five stocks we like better.
- Cumberland completed the sale of its branded U.S. commercial portfolio to Apotex for $100 million
